v3.26.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance at Dec. 31, 2024 $ 120,751 $ 60 $ 484,077 $ 170 $ (363,556)
Beginning Balance, Shares at Dec. 31, 2024   59,967,814      
Exercise of pre-funded warrants 2 $ 2      
Exercise of pre-funded warrants (Shares)   1,611,215      
Issuance of restricted common stock, net of tax withholdings (2)   (2)    
Issuance of restricted common stock, net of tax withholdings, (Shares)   22,728      
Issuance of common stock under employee stock purchase plan ("ESPP") (Shares)   29,619      
Stock-based compensation 3,631   3,631    
Net unrealized loss on marketable debt securities (121)     (121)  
Net loss (21,158)       (21,158)
Ending balance at Mar. 31, 2025 103,103 $ 62 487,706 49 (384,714)
Ending balance (in shares) at Mar. 31, 2025   61,631,376      
Beginning balance at Dec. 31, 2024 120,751 $ 60 484,077 170 (363,556)
Beginning Balance, Shares at Dec. 31, 2024   59,967,814      
Net unrealized loss on marketable debt securities (175)        
Net loss (39,512)        
Ending balance at Jun. 30, 2025 87,643 $ 62 490,654 (5) (403,068)
Ending balance (in shares) at Jun. 30, 2025   62,018,135      
Beginning balance at Mar. 31, 2025 103,103 $ 62 487,706 49 (384,714)
Beginning Balance, Shares at Mar. 31, 2025   61,631,376      
Issuance of restricted common stock, net of tax withholdings (67)   (67)    
Issuance of restricted common stock, net of tax withholdings, (Shares)   386,759      
Stock-based compensation 3,015   3,015    
Net unrealized loss on marketable debt securities (54)     (54)  
Net loss (18,354)       (18,354)
Ending balance at Jun. 30, 2025 87,643 $ 62 490,654 (5) (403,068)
Ending balance (in shares) at Jun. 30, 2025   62,018,135      
Beginning balance at Dec. 31, 2025 53,408 $ 63 496,469 53 (443,177)
Beginning Balance, Shares at Dec. 31, 2025   62,690,229      
Issuance of restricted common stock, net of tax withholdings (25)   (25)    
Issuance of restricted common stock, net of tax withholdings, (Shares)   141,017      
Stock-based compensation 1,210   1,210    
Net unrealized loss on marketable debt securities (53)     (53)  
Net loss (23,272)       (23,272)
Ending balance at Mar. 31, 2026 31,268 $ 63 497,654   (466,449)
Ending balance (in shares) at Mar. 31, 2026   62,831,246      
Beginning balance at Dec. 31, 2025 $ 53,408 $ 63 496,469 53 (443,177)
Beginning Balance, Shares at Dec. 31, 2025   62,690,229      
Stock options exercised (Shares) 28,706        
Net unrealized loss on marketable debt securities $ (57)        
Net loss (48,618)        
Ending balance at Jun. 30, 2026 11,440 $ 63 503,176 4 (491,795)
Ending balance (in shares) at Jun. 30, 2026   63,434,936      
Beginning balance at Mar. 31, 2026 31,268 $ 63 497,654   (466,449)
Beginning Balance, Shares at Mar. 31, 2026   62,831,246      
Issuance of restricted common stock and other awards, net of tax withholdings (53)   (53)    
Issuance of restricted common stock and other awards, net of tax withholdings, (Shares)   574,984      
Stock options exercised 47   47    
Stock options exercised (Shares)   28,706      
Stock-based compensation 5,528   5,528    
Net unrealized loss on marketable debt securities (4)     (4)  
Net loss (25,346)       (25,346)
Ending balance at Jun. 30, 2026 $ 11,440 $ 63 $ 503,176 $ 4 $ (491,795)
Ending balance (in shares) at Jun. 30, 2026   63,434,936